Research with Recreational Cannabis in Germany - Which Agency is Responsible?

Recommendation
20/21 May 2025
Vienna, Austria
With a workshop about the development of ADCs
In December 2024, the German Bundesgesetzblatt (Federal Law Gazette) published the Regulation determining the competent authority for issuing licenses and monitoring the handling of cannabis for scientific purposes in accordance with the German Konsumcannabisgesetz (Consumer Cannabis Act). As a result, the Bundesinstitut für Arzneimittel und Medizinprodukte (German Federal Institute for Drugs and Medical Devices, BfArM) is no longer in charge of processing research applications for recreational cannabis and industrial hemp; this responsibility now lies with the Bundesanstalt für Landwirtschaft und Ernährung (German Federal Office for Agriculture and Food, BLE).
In accordance with the regulation, the BLE will review the relevant research applications and monitor the authorized projects. Previously, this task was the responsibility of the BfArM, who will remain the competent authority for research with medicinal cannabis. Research on and with recreational cannabis is therefore possible, but requires a license. Applicants must meet the criteria set out in the Consumer Cannabis Act, demonstrate the required expertise and provide evidence of their scientific interest. Universities as well as private companies may submit research applications. The research aims to reduce the illicit market, improve public health and bring more facts to the cannabis debate.
Further information can be found in the Regulation on the determination of the competent authority for the licensing and supervision of the handling of cannabis for scientific purposes under the Consumer Cannabis Act (Konsumcannabis-Wissenschafts-Zuständigkeitsverordnung - KCanWissZustV).
Related GMP News
02.04.2025BfArM Guideline for the Application for a Licence to Cultivate Cannabis
27.03.2025Can RWD support Medical Cannabis Evalution?
27.03.2025Omission of the German Cannabis Monograph
04.03.2025FDA requests Information on the Use of Cannabis Products in Animals
04.03.2025How to Classify Borderline Products?
30.01.2025FDA seeks Feedback on Opiate Alkaloid Content of Poppy Seeds